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Introduction
Fluoroquinolones are gaining widespread accept-
ance in veterinary medicine as they have broad
spectrum activity against Gram-negative and
Gram-positive bacteria, mycoplasma, ricketsia as
well as against bacteria resistant to other antibiotics
(Brown, 1996). At present only few fluoro-
quinolones are used in veterinary medicine. Resist-
ance of bacteria against fluoroquinolone is great
threat for future survival of the fluoroquinolone
drugs as an antibiotic class in veterinary medicine
(Sharma et al., 1994). Gatifloxacin is a newer
fourth generation fluoroquinolones. It is active L -
isomer of the racemate ofloxacin having twice an-
timicrobial activity than parent compound (Sar-
avolatz and Leggett, 2003). The numbers of
pharmacokinetic studies are being undertaken in
domestic animals with a view to adopt this drug in
veterinary medicine as well. It’s spectrum of activ-
ity and pharmacokinetic properties favour its use
in veterinary practice. Pharmacokinetics of gati-
floxacin have been studied in buffalo calves
(Raipuria et. al., 2006, Raipuria et. al., 2007a,
Raipuria et. al., 2007b) and goats (Verma and Roy,
2006, Verma et. al., 2007). However, the data on
safety of repeated oral administration of gati-
floxacin in broiler chickens are lacking. Therefore,
the present study was planned to evaluate safety of
gatifloxacin following multiple oral dose adminis-
tration in broiler chickens.
Materials and methods
Experimental Animals
The present study was conducted on 14 broiler
chickens reared at Central Poultry Research Sta-
tion, Anand Agricultural University, Anand, Gu-
jarat, India. The birds were weighing between
1.50-2.00 kg on 8-10 weeks of age. The birds were
examined clinically to evaluate health status and to
rule out the possibility of any diseases. They were
kept individually as a single bird per cage and were
maintained on standard antibiotics free starter ra-
tion. Water was provided ad libitum. Standard man-
agemental practices were followed to keep the
birds free from stress. The experimental protocol
was approved by the institutional animal ethics
committee (IAEC).
Drugs and chemicals
Gatifloxacin sesquihydrate technical grade powder
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Abstract
Gatifloxacin is a fluoroquinolone having broad-spectrum activity and good antibacterial activity at low plasma/tissue
concentration. The present study was designed to investigate safety of gatifloxacin (10 mg/kg body weight) after repeated
oral administration at 12 hours interval for 14 days in broiler chickens and to determine tissue concentration of the drug fol-
lowing oral administration (10 mg/kg body weight) for 5 days. Repeated oral administration of gatifloxacin in broiler chickens
was found safe based on evaluation of hematological (Hb, PCV and TLC), biochemical (AST, ALT, ALP, LDH, Serum uric
acid, Serum Creatinine, Blood glucose and Total bilirubin) and histopathology of liver, kidney, heart and joint cartilage. Drug
concentration in tissue was determined using High Performance Liquid Chromatography (HPLC). The concentration of gat-
ifloxacin was found 0.75 ± 0.04 µg/g after fourth dose and 0.22 ± 0.07 µg/g after tenth dose respectively in liver, whereas in
skeletal muscles the concentration of gatifloxacin was below the limit of quantification after fourth dose and after tenth dose
gatifloxacin was not detected.
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was received as a gift sample from Sun Pharma-
ceutical Ltd, Vadodara, Gujarat. Gatifloxacin oral
tablet (200 mg; Gatispan®, Lupin Ltd., Mumbai)
was purchased from local market. Acetonitrile,
methanol, ethanol, triethylamine, perchloric acid
(about 70%), ortho-phosphoric acid (min. 58%, an-
alytical grade) and deionised water of HPLC grade
were purchased from Merck Limited, Mumbai.
Experimental Design for Safety Assessment
Eight broiler chickens were employed to assess
safety of the drug. Birds were administered 10
mg/kg body weight of gatifloxacin at 12 hours in-
terval for 14 days. Blood samples were withdrawn
from wing vein into sterile heparinized (2 ml) and
non-heparinized (3 ml) test tubes at 0 day (before
drug administration) and on 3rd, 5th, 7th, 9th, 11th,
13th and 15th day for haematological [Hemoglobin
(Hb), Packed cell volume (PCV) and Total leuko-
cytes count (TLC)] and serum biochemical analysis
[Aspartate aminotransferase (AST), Alanine
transaminase (ALT), Alkaline phosphatase (ALP),
Lactate dehydrogenase (LDH), Serum uric acid,
Serum creatinine, Blood glucose and Total biliru-
bin], respectively. Haemoglobin was determined by
Sahli’s acid hematin method, PCV and TLC as de-
scribed by Schalm, (1967). Biochemical parame-
ters were estimated using standard assay kits (Crest
Biosystems, A Division of Coral Clinical Systems,
Goa, India) with the help of clinical chemistry
analyser (Junior Selectra, Vital Scientific NV) at
Teaching Veterinary Clinical Service Complex,
Veterinary College, AAU, Anand.. Birds were scar-
ified to collect tissue samples (liver, kidney and
femoro-tibial and tibio-tarsal joint cartilages) for
histopathological examination at 15th day.  Tissues
were processed for histopathological examination
by standard procedure and were stained with hema-
toxylin and eosin (H & E). Statistical analysis of
data was done by software SPSS (Version 12.0.1). 
Experimental Design for Tissue Residue Assess-
ment
Six broiler chickens were employed to determine
the accumulation of the drug in tissues following
multiple oral administrations at dose rate of 10
mg/kg body weight at 12 hours interval for 5 days.
Birds were sacrificed at 12 hours after the last dose
of the drug to collect the samples of liver and skele-
tal muscle. The drug concentration in tissue sam-
ples was determined by HPLC assay (Santoro et
al., 2006 and Najma Sultana et al., 2006). 
Extraction of gatifloxacin from Tissues
The extraction of gatifloxacin from tissues was
done by using a modified method previously re-
ported by Goudah, (2009). A 0.5 g sample of tissue
was homogenized at ambient temperature with 2ml
of acetonitrile, centrifuged at 5000 revolutions per
minute (rpm) for 10 minutes; the supernatant was
diluted 4-fold with mobile phase and mixed on vor-
tex mixer for 1 minute. Five hundred microlitre of
supernatant was transferred to a 2 ml micro-cen-
trifuge tube. 2.5 μg of ciprofloxacin was added as
an internal standard in each sample.  Thereafter, the
perchloric acid (50 μl) was added in supernatant to
precipitate proteins. The mixture was shaken on a
vortex mixer for 1 minute and centrifuged for 2
minute at 5000 revolutions per minute (rpm). The
supernatant was decanted in glass vials and 20 μl
supernatant was injected into the loop injector
using 25 μl glass syringe.
High Performance Liquid Chromatography
(HPLC) Assay:
The HPLC system (Laballiance, USA) comprised
of quaternary gradient solvent delivery pump
(model AIS 2000) and UV detector (model 500).
Chromatographic separation was done on reverse
phase C18 column (Thermo, 5 µ ODS; 250 X 4.6
mm ID) at room temperature. Data integration was
performed using software Clarity (Version
2.4.0.190). The mobile phase consists of a mixture
of water containing 1% triethylamine, acetonitrile
and methanol (85:15:15 v/v) adjusted to pH 3.0
with ortho-phosphoric acid.  Mobile phase was fil-
tered through 0.45 μ filter and pumped into column
at a flow rate of 1.0 mL/min at ambient tempera-
ture.  The effluent was monitored at 290 nm. 
Standard curves were also prepared using ho-
mogenates of tissues like liver and skeletal muscle
in mobile phase.  Known concentrations of gati-
floxacin were prepared by diluting the stock stan-
dard with drug-free poultry tissue homogenate. The
sensitivity of the assay method was 0.1 μg gati-
floxacin per ml.  The mean correlation coefficient
R2 was 0.999 in both liver and skeletal muscle tis-
sue homogenate.
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Results
After oral administration of the drug at the dose
rate of 10 mg/kg body weight repeated at twelve
hours interval, the values of hematological and bio-
chemical parameters were evaluated and are pre-
sented in Table 1 and 2, respectively. No alterations
in hematological and serum biochemical parame-
ters have been found in the present study.
All organs including liver, heart and kidney were
found with normal colour, texture and consistency
on gross necropsy examination of the birds. On
histopathological examination, no alterations at
cellular level have been found in liver (Fig. 1),
heart (Fig. 2), kidney (Fig. 3) and joint cartilage
(Fig. 4).
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Table 1. Hematological parameters (mean ± S.E.) after oral administration of gatifloxacin (10mg/ kg of
body weight) in broiler chicken (n=8).
Non significant at P < 0.05 level
Table 2. Biochemical parameters (m ± S.E.) after oral administration of gatifloxacin (10mg/kg of body
weight) in broiler chicken (n=8).
Non significant at P < 0.05 level
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Fig. 1. Histopathological section of Liver
Fig. 2. Histopathological section of Heart.
Fig. 3. Histopathological section of Kidney.
Discussion
After oral administration of the drug at the dose
rate of 10 mg/kg body weight repeated at twelve
hours interval, the values of hematological and bio-
chemical parameters were evaluated and are pre-
sented in Table 1 and 2, respectively. No alterations
in hematological and serum biochemical parame-
ters have been found in the present study. It is in
agreement with the no significant alterations in
haematological and biochemical parameters re-
ported in layer birds (Patel et al., 2009) and broiler
birds (Varia, 2008) at 10 mg/kg of body weight
dose of levofloxacin respectively. However mild
transient decrease in serum glucose and mild tran-
sient intravenous site reaction was associated with
the end of the 1-hour infusion of gatifloxacin daily
via intravenous route for 14 days in healthy adult
men by Gajjar et al. (2000). 
In the present study, all organs including liver,
heart and kidney were found with normal colour,
texture and consistency on gross necropsy exami-
nation of the birds. On histopathological examina-
tion, no alterations at cellular level have been found
in liver (Fig. 1), heart (Fig. 2), kidney (Fig. 3) and
joint cartilage (Fig. 4). Potential of the drug to in-
duce arthropathic changes was evaluated by obser-
vation of the gait, behaviour and reaction to
palpation of joint (pain) during the experiment and
by histopathological examination of joint cartilage
in broiler chickens. In the present study, no abnor-
mality in gait and pain at joints were observed dur-
ing the treatment period. Moreover,
histopathological examination of the joint cartilage
did not reveal any microscopic changes in the ar-
ticular cartilages of treated birds. However exces-
sive dosages of various quinolones have caused
lesions in articular cartilages of skeletally immature
dogs, rats and other skeletally immature laboratory
animals (Gough et al. 1979; Howard et al. 1979;
Kato and Onodera, 1988, Tatsumi et al. 1978).
Gross and microscopic observations of the present
study are in agreement with the result observed in
broiler and layer birds treated with repeated oral
dose of levofloxacin at the rate of 10 mg/kg of body
weight (Patel et al., (2009),Varia et al., (2009)).
Ciprofloxacin was also found safe in cow calves
following repeated administration at dose rate 5
mg/kg body weight as no alterations were found in
joint cartilage (Bhavsar et al., 2004). 
Following oral administration of gatifloxacin at
the dose rate of 10 mg/kg at 12 hours interval for 5
days revealed gatifloxacin concentration in liver
was 0.75±0.04 µg/g after fourth dose and
0.22±0.07 µg/g after tenth dose respectively,
whereas in skeletal muscles the concentration was
below the limit of quantification (0.012±0.002
µg/g) after fourth dose and after tenth dose gati-
floxacin was not detected. This persistence of drug
in tissue indicates the high volume of distribution
and low protein binding of gatifloxacin in chickens.
The equivalent high concentration of pefloxacin
(10 mg/kg of body weight) after 1 day of last dose
was 3.20±0.40 in liver and 1.42±0.18 in muscle,
whereas tissue concentration of moxifloxacin (5
mg/kg of body weight) after 72 hour was 0.27±0.06
in liver and 0.13±0.06 in skeletal muscle obtained
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Fig. 4. Histopathological section of Joint cartilage.
by Pant et al. (2005) and Goudah (2009) in broiler
chickens respectively. The results indicate that, for
daily oral administration of gatifloxacin at 10
mg/kg of body weight repeated at twelve hours in-
terval following four and ten oral doses, a pres-
laughter withdrawal time of more than 7 days is
needed to ensure that the drug is eliminated from
the tissues.
Conclusion
Following multiple oral administration, gati-
floxacin shown good accumulation in the tissues at
third day. Results obtained in the present study in-
dicate that gatifloxacin is well tolerated following
multiple oral administrations at 10 mg/kg body
weight in broiler bird.
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